Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment (DCE)
2022年6月2日 更新者：Bristol-Myers Squibb
Patient Preference for Treatment of Moderate-To-Severe Psoriasis in Japan
The purpose of this observational study is to identify and weight the treatment attributes from the moderate-to-severe Psoriasis (PsO) patients' perspective in Japan.
研究概览
地位
完全的
条件
研究类型
观察性的
注册 (实际的)
232
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
North Carolina
-
Morrisville、North Carolina、美国、27560
- Local Institution
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
20年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
取样方法
非概率样本
研究人群
A total of 10 participants, diagnosed as moderate-to-severe Psoriasis (PsO) by a clinician were included in the Phase 1 qualitative interview
A total of 200 participants, self-reported as moderate-to-severe PsO, were included in the Phase 2 online survey
描述
Inclusion Criteria:
- Diagnosis of moderate-to-severe Psoriasis (PsO) by physician (phase 1) or self-reported (phase 2)
- Currently taking systemic psoriasis treatment
- Japanese resident aged 20 years and older
Exclusion Criteria:
- Unable or unwilling to provide informed consent
- Diagnosis of guttate, inverse, pustular, erythrodermic, or drug-induced psoriasis
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
|---|
|
Phase 1
Participants with moderate-to-severe Psoriasis (PsO) in Japan who have been recruited based on eligibility criteria
|
|
Phase 2
Self-reported moderate-to-severe Psoriasis (PsO) participants in Japan
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Psoriasis (PsO) patient preferences of moderate-to-severe systemic treatment atrribute
大体时间：Within 60 minutes of survey/interview
|
Within 60 minutes of survey/interview
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 1: Sex
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Age
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of PsO participants in Phase 1: Time since PsO diagnosis
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of PsO participants in Phase 1: Severity of PsO
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of PsO participants in Phase 1: Current treatments for PsO
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of PsO participants in Phase 1: Time on current PsO treatment
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Residence
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Employment status
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Education
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of PsO participants in Phase 1: Total number of previous treatments
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of PsO participants in Phase 1: Previous treatments for PsO
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of PsO participants in Phase 1: Level of income
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Sex
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Age
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Height
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Weight
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Residence
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Employment status
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Type of occupation
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Education
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Time since PsO diagnosis
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Self-reported severity
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Current treatments for PsO
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Time on current PsO treatment
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Previous treatments for PsO
大体时间：At Baseline
|
At Baseline
|
|
Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Comorbid conditions of interest
大体时间：At Baseline
|
At Baseline
|
|
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Level of income
大体时间：At Baseline
|
At Baseline
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2021年10月1日
初级完成 (实际的)
2022年2月7日
研究完成 (实际的)
2022年2月7日
研究注册日期
首次提交
2021年9月23日
首先提交符合 QC 标准的
2021年9月23日
首次发布 (实际的)
2021年10月4日
研究记录更新
最后更新发布 (实际的)
2022年6月6日
上次提交的符合 QC 标准的更新
2022年6月2日
最后验证
2022年5月1日
更多信息
与本研究相关的术语
其他研究编号
- IM011-174
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.